Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ANIX | Common Stock | Options Exercise | $309K | +120K | +15.5% | $2.58 | 894K | Jul 27, 2023 | Direct | |
transaction | ANIX | Common Stock | Tax liability | -$309K | -87K | -9.74% | $3.55 | 807K | Jul 27, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ANIX | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -120K | -100% | $0.00* | 0 | Jul 27, 2023 | Common Stock | 120K | $2.58 | Direct | F2 |
Id | Content |
---|---|
F1 | The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options. |
F2 | Right-To-Buy, pursuant to a stock option grant dated November 8, 2013. |